Choosing the appropriate pharmacotherapy for breast cancer during pregnancy: what needs to be considered?-Reference-Cited by-同舟云学术

Choosing the appropriate pharmacotherapy for breast cancer during pregnancy: what needs to be considered?

Published:2023-12-12 Issue:18 Volume:24 Page:1975-1984
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Favero Diletta¹²^ORCID,Lapuchesky Laura Sabina³,Poggio Francesca²,Nardin Simone¹²,Perachino Marta¹²,Arecco Luca¹²,Scavone Graziana²,Ottonello Silvia²,Latocca Maria Maddalena²,Borea Roberto¹²,Puglisi Silvia¹²,Cosso Maurizio⁴,Fozza Alessandra⁵,Spinaci Stefano⁶,Lambertini Matteo¹²^ORCID

Affiliation:

1. Department of Internal Medicine and Medical Specialties (Di.M.I.), School of Medicine, University of Genova, Genoa, Italy

2. Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

3. Department of Medical Oncology, Instituto Alexander Fleming, University of Buenos Aires, Buenos Aires, Argentina

4. Department of Radiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

5. Department of Radiotherapy, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

6. Division of Breast Surgery, Ospedale Villa Scassi, Genoa, Italy

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2023.2293167

Reference92 articles.

1. The definition of pregnancy-associated breast cancer is outdated and should no longer be used

2. Pregnancy-Associated Cancer: A U.S. Population-Based Study

3. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997

4. Frequency of Pregnancy-Associated Cancer: A Systematic Review of Population-Based Studies

5. Cancer and Pregnancy: A Comprehensive Review